Adeno-associated virus gene therapy(Surv BioPharma Inc)

N/A

Report date: 2025/12/19 09:25:35

Base Information

Drug NameAdeno-associated virus gene therapy(Surv BioPharma Inc)

Drug Alias NameAAV gene therapy(Surv BioPharma Inc)

ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsObesityDiabetes MellitusMetabolic Dysfunction-Associated Steatotic Liver Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesSurv BioPharma Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsObesityDiabetes MellitusMetabolic Dysfunction-Associated Steatotic Liver Disease

Inactive IndicationsN/A

ATC CodeN/A